HIGHLIGHTS
- who: Satoshi Yamasaki and Takahiko Horiuchi from the Department of Internal Medicine, Kyushu University Beppu Hospital, Beppu, Japan have published the Article: Hypoxia-Inducible Factor-Prolyl-Hydroxylase and Sodium-Glucose Cotransporter 2 Inhibitors for Low-Risk Myelodysplastic Syndrome-Related Anemia in Patients with Chronic Kidney Disease: A Report of Three Cases, in the Journal: (JOURNAL) of 28/Oct/2022
- what: The aim of this case series was to investigate the synergistic effects of daprodustat and dapagliflozin, which corrects CKD-related anemia by promoting endogenous erythropoietin production and normalizing iron metabolism in LR-MDS patients with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.